SOFIA (Bulgaria), October 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its net proft rose to 33.5 million levs ($19.0 million/17.1 million euro) in the first nine months of 2019 on the back of an increase in sales, including a 23% rise in sales in Ukraine.Â